Results 161 to 170 of about 6,541,908 (257)

Decomposition of s - Concentration Curves [PDF]

open access: yes
For any given order of stochastic dominance, standard concentration curves are decomposed into contribution curves corresponding to within-group inequalities, between-group inequalities, and transvariational inequalities.
Paul Makdissi, Stéphane Mussard
core  

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

LOESS-Based Cephalometric Growth Curves for Clinical Assessment of Craniofacial Development: A Cross-Sectional Study. [PDF]

open access: yesDent J (Basel)
Cruz-Hervert LP   +11 more
europepmc   +1 more source

Growth Curves of Chinese Children with Androgen Insensitivity Syndrome: A Multicenter Registry Study. [PDF]

open access: yesJ Pers Med, 2022
Zhao X   +12 more
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Evaluating Different Growth Scenarios for Organic Farming Using Bayesian Techniques [PDF]

open access: yes
Different views exist on the future development of organic agriculture. The Dutch government believes that in 2010 10% of the farm land will be used for organic farming.
Gardebroek, Cornelis
core  

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Fine Motor Development Growth Curves for Down Syndrome. [PDF]

open access: yesJ Child Neurol
Wiebers Jensen M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy